---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-003492"
form_type: "8-K"
ticker: "NEUP"
cik: "0001191070"
company_name: "Neuphoria Therapeutics Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T01:44:06.707353+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Neuphoria Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter confirming compliance with Minimum Bid Price Rule 5450(a)(1) on Jan 10, 2025.
- Common stock (NEUP) closed at $1.00 or higher for 10 consecutive business days from Dec 24, 2024 to Jan 8, 2025.
- Deficiency letter previously disclosed in July 2024; compliance deadline was Jan 7, 2025.
- Matter is now closed; company avoids potential delisting.

## SEC filing metadata
- accession: 0001213900-25-003492
- form_type: 8-K
- ticker: NEUP
- cik: 0001191070
- company_name: Neuphoria Therapeutics Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1191070/000121390025003492/0001213900-25-003492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1191070/000121390025003492/ea0227706-8k_neupho.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-003492
- JSON: https://secwatch.observer/filing/0001213900-25-003492.json
- Plain text: https://secwatch.observer/filing/0001213900-25-003492.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.